Atlas Trials

Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

Clinical trial NCT03849560 · COMPLETED

Trial details

NCT number
NCT03849560
Sponsor
NPO Petrovax
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2016-11-01
Primary completion
2017-06-01
Enrollment
612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.